October Newsmakers

Breast Cancer State of the Science Summit

Duke Cancer Institute faculty provided insight into the exciting breast cancer research being conducted here, in interviews during the 2019 OncLive State of the Science Summit on Breast Cancer last month in Durham.

• Duke Cancer Institute Faculty Describe Latest Efforts in Breast Cancer Research  Features Kelly Marcom, MD; Carey Anders, MD; Susan Dent, MD; Jeremy Force, DO; Gretchen G. Kimmick, MD, MS; Sarah Sammons, MD; Kelly Westbrook, MD
   
• CDK4/6 Inhibitors Continue to Change Practice in HR+ Breast Cancer
  Sarah Sammons, MD
   
• WATCH: Dr. Marcom on Liquid Biopsies in Breast Cancer
  Features Kelly Marcom, MD
   
• Genomics Are Key to Unlocking Breast Cancer Biology
  Features Kelly Marcom, MD
   
• WATCH: Dr. Westbrook on Combatting Tumor Heterogeneity in HER2+ Breast Cancer  Features Kelly Westbrook, MD
   
• WATCH: Dr. Anders Discusses the Use of Neratinib/Capecitabine for HER2-Positive Brain Metastases
  Features Carey Anders, MD
   
• WATCH: Dr. Anders on Sequencing Strategies in the Setting of HER2+ Brain Metastases
  Features Carey Anders, MD
   
• Broader Trial Eligibility Criteria Expands Options for Brain Mets in Breast Cancer
  Features Carey Anders, MD
   
• Expert Emphasizes Exercise to Minimize Cardiac Toxicity in Breast Cancer
  Features Susan Dent, MD
   
• Immunotherapy Begins New Therapeutic Path in Metastatic TNBC
  Features Jeremy Force, DO

Other News

WATCH: ESMO 2019 | Cell-Free DNA for GI therapy personalization (VJ Oncology)
Features John Strickler, MD

Inflammatory Breast Cancer Has Diagnostic Challenges, Requires More Awareness (OncLive)
Features Duke Cancer Center

WATCH: Novel Agents Are Changing the Prostate Cancer Treatment Landscape (OncLive)
Features Daniel George, MD

WATCH: Dr. George on Investigational Agents Downstream of the Androgen Receptor in Prostate Cancer (OncLive)
Features Daniel George, MD

WATCH: Dr. Zhang on the IMvigor130 Trial in Metastatic Urothelial Cancer (OncLive)
Features Tian Zhang, MD

Open-Minded Research for Therapeutic Options Needed in TGCT (OncLive)
Features William Eward, MD, DVM

Dr. George on the Use of Radium-223 in Prostate Cancer (OncLive)
Features Daniel George, MD

The Perilous Power of the Preacher’s Wife (New York Times)
Kate Bowler, PhD

Duke wins $5 million grant to help scientists identify environmental contaminants (Raleigh News & Observers)
Features Heather S. Stapleton, PhD

$5 Million Grant Will Fund New Laboratory for Environmental Analysis (Nicholas School of the Environment)
Features Heather S. Stapleton, PhD

Blue Devil of the Week: Searching for Answers in the Genetic Code (Duke Today)
Features Sue Jinks-Robertson, PhD

Letter: Faculty urge Duke to ban vaping (The Chronicle)
Features Sven-Eric Jordt, PhD and Cynthia E Kuhn

Curing Pediatric Cancer in Tanzania: Kristin Schroeder Breaks Through Barriers to Help Families (SOM Magnify)
Features Kristin Schroeder, MD, MPH

Editor's Note: "I'm Not Done with Life Yet" (Duke Today)
Features Duke patient

Papers

Clinical and pathological stage discordance among 433,514 breast cancer patients. American Journal of Surgery. October 2019. Jennifer K. Plichta, Samantha M. Thomas, Amanda R. Sergesketter, Rachel A. Greenup, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Nina Tamirisa, Terry Hyslop, Shelley Hwang.

Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma. Annals of Surgical Oncology. October 2019. M. J. Thornton, H. V. Williamson, K. E. Westbrook, R. A. Greenup, J. K. Plichta, L. H. Rosenberger, A. M. Gupta, T. Hyslop, E. S. Hwang, O. M. Fayanju.

Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer. Cancer. Aug. 27, 2019. Laura J. Havrilesky, MD, MHSc; Jui‐Chen Yang, MEM; Paula S. Lee, MD, MPH; Angeles Alvarez Secord, MD, MHSc; Jessie A. Ehrisman, BS; Brittany Davidson, MD; Andrew Berchuck, MD; Kathleen M. Darcy, PhD; G. Larry Maxwell, MD; Shelby D. Reed, PhD.